Ikaros modulates cholesterol uptake: A link between tumor suppression and differentiation

Cancer Research

Volumn 68, Issue 10, 2008, Pages 3715-3723

  Loeper, Siobhan ^a,b   Asa, Sylvia L ^a,b   Ezzat, Shereen ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HISTONE H3; IKAROS TRANSCRIPTION FACTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; CHOLESTEROL; IKZF1 PROTEIN, HUMAN; ZFPN1A1 PROTEIN, MOUSE;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHOLESTEROL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FLUOROMETRY; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR DIFFERENTIATION; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; FEMALE; GENETICS; MALE; METABOLISM; NEOPLASM; PHYSIOLOGY; TRANSGENIC MOUSE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CHOLESTEROL; FEMALE; GOLGI APPARATUS; HUMANS; IKAROS TRANSCRIPTION FACTOR; MALE; MICE; MICE, TRANSGENIC; NEOPLASMS; RECEPTORS, LDL;

EID: 45549101308     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0103     Document Type: Article

References (50)

1. Georgopoulos K, Moore DD, Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992;258:808-12.
2. Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 1994;14:7111-23.
3. Molnar A, Wu P, Largespada DA, et al. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol 1996;156:585-92.
4. Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996; 15:5358-69.
5. Wang JH, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996;5:537-49.
6. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2002;2:162-74.
7. Molnar A, Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994;14:8292-303.
8. Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 2000;14:2146-60.
9. Yu S, Asa SL, Ezzat S. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol Endocrinol 2002;16: 1069-78.
10. Ezzat S, Mader R, Yu S, Ning T, Poussier P, Asa SL. Ikaros integrates endocrine and immune system development. J Clin Invest 2005;115:1021-9.
11. Winandy S, Wu P, Georgopoulos K. Adominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995;83:289-99.
12. Avitahl N, Winandy S, Friedrich C, Jones B, Ge Y, Georgopoulos K. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 1999;10:333-43.
13. Sun L, Heerema N, Crotty L, et al. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 1999;96:680-5.
14. Sun L, Crotty ML, Sensel M, et al. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 1999;5:2112-20.
15. Nakase K, Ishimaru F, Avitahl N, et al. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res 2000;60:4062-5.
16. Ezzat S, Yu S, Asa SL. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5′ fibroblast growth factor receptor-4 promoter. Am J Pathol 2003;163:1177-84.
17. Ezzat S, Zhu X, Loeper S, Fischer S, Asa SL. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to upregulate a survival signal in pituitary cells. Mol Endocrinol 2006;20:2976-86.
18. Asa SL. Tumors of the pituitary gland. Atlas of tumor pathology, third series, fascicle 22. Washington (DC): Armed Forces Institute of Pathology; 1998.
19. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization classification of tumours: tumours of endocrine organs. Lyon: IARC; 2004.
20. Zhu X, Lee K, Asa SL, Ezzat S. Epigenetic silencing through DNAand histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells. Am J Pathol 2007;170:1618-28.
21. Sato R, Miyamoto W, Inoue J, Terada T, Imanaka T, Maeda M. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem 1999;274: 24714-20.
22. Sudhof TC, Van der Westhuyzen DR, Goldstein JL, Brown MS, Russell DW. Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J Biol Chem 1987;262:10773-9.
23. Kong WJ, Liu J, Jiang JD. Human low-density lipoprotein receptor gene and its regulation. J Mol Med 2006;84:29-36.
24. Zhu X, Asa SL, Ezzat S. Ikaros is regulated through multiple histone modifications and deoxyribonucleic acid methylation in the pituitary. Mol Endocrinol 2007; 21:1205-15.
25. Teupser D, Thiery J, Walli AK, Seidel D. Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim Biophys Acta 1996;1303: 193-8.
26. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A 2000;97:9052-7.
27. Horton JD, Goldstein JL, Brown MS. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol 2002;67:491-8.
28. Rawson RB. The SREBP pathway - insights from Insigs and insects. Nat Rev Mol Cell Biol 2003;4:631-40.
29. Kim J, Sif S, Jones B, et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 1999;10:345-55.
30. Koipally J, Renold A, Kim J, Georgopoulos K. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J 1999;18:3090-100.
31. Smith PM, Cowan A, White BA. The low-density lipoprotein receptor is regulated by estrogen and forms a functional complex with the estrogen-regulated protein ezrin in pituitary GH3 somatolactotropes. Endocrinology 2004;145:3075-83.
32. Hsu HY, Nicholson AC, Hajjar DP. Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J Biol Chem 1994;269:9213-20.
33. Abbass SAA, Asa SL, Ezzat S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1160-6.
34. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta 2000;1529:164-74.
35. Tosi MR, Tugnoli V. Cholesteryl esters in malignancy. Clin Chim Acta 2005;359:27-45.
36. Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood 1994;84:2689-98.
37. Vitols S, Gunven P, Gruber A, Larsson O. Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas. Biochem Pharmacol 1996;52: 127-31.
38. Kapoor GS, Atkins BA, Mehta KD. Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth. Mol Cell Biochem 2002;236:13-22.
39. Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 1993;268: 17489-94.
40. Kumar A, Middleton A, Chambers TC, Mehta KD. Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 1998;273: 15742-8.
41. Qiu S, Korwek KM, Weeber EJ. Afresh look at an ancient receptor family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol Learn Mem 2006;85:16-29.
42. Mulder M, Jansen PJ, Janssen BJ, et al. Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis 2004;16: 212-9.
43. Hua X, Yokoyama C, Wu J, et al. SREBP-2, a second basic-helix-loop-helix- leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci U S A 1993; 90:11603-7.
44. Oh J, Choi YS, Kim JW, et al. Inhibition of low density lipoprotein receptor expression by long-term exposure to phorbol ester via p38 mitogen-activated protein kinase pathway. J Cell Biochem 2005;96: 786-94.
45. Koipally J, Georgopoulos K. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem 2000; 275:19594-602.
46. Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. Unconventional potentiation of gene expression by Ikaros. J Biol Chem 2002;277:13007-15.
47. Yu S, Zheng L, Asa SL, Ezzat S. Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter. Am J Physiol Endocrinol Metab 2002;283:E490-5.
48. Chen JK, Hoshi H, McKeehan WL. Heparin-binding growth factor type one and platelet-derived growth factor are required for the optimal expression of cell surface low density lipoprotein receptor binding activity in human adult arterial smooth muscle cells. In Vitro Cell Dev Biol 1988;24:199-204.
49. Sassano A, Katsoulidis E, Antico G, et al. Suppressive effects of statins on acute promyelocytic leukemia cells. Cancer Res 2007;67:4524-32.
50. Inano H, Suzuki K, Wakabayashi K. Chemoprevention of radiation-induced mammary tumors in rats by bezafibrate administered together with diethylstilbestrol as a promoter. Carcinogenesis 1996;17:2641-6.